This role serves as the single authoritative commercial voice to R&D and Business Development to drive long-range strategy for the Inflammation & Immunology and Rare Disease portfolios.
Base: $313,100.00 to $521,900.00; Bonus/Equity: 35% target bonus plus share-based long term incentive; Benefits: 401(k) match, paid vacation, health coverage
Must-have
Nice-to-have
Must have permanent work authorization in the U.S.